Treatment and Management:
In cases without secondary complication such as serous retinal detachment or CNVM formation, no treatment is indicated for FCE3. Patients should nonetheless be monitored annually for such potential complications. Patients should be counselled appropriately and reassured that the majority of cases are non-progressive and not visually debilitating.

Image credits: Margolis et al. (2011)2


